Tesamorelin's Effects Beyond Visceral Fat

16 Aug 2026 · 1 min
1:27

In this explanatory segment, the speaker reviews a 2020 Mass General Hospital study and a 12‑month clinical trial showing that tesamorelin markedly reduces liver fat—by about 37% after a year of treatment. The reduction is linked to activation of growth‑hormone‑releasing‑hormone (GHRH) receptors, which up‑regulates the master mitochondrial biogenesis factor PGC‑1α, leading to new mitochondria formation and increased fatty‑acid oxidation. The speaker also notes that tesamorelin down‑regulates inflammatory cytokines produced by visceral fat, thereby improving hormonal health. Finally, the segment highlights emerging evidence that tesamorelin can lessen neuroinflammation and boost prefrontal cortex activity, translating into better executive function and memory in older adults.

Chapters

More from Ashley

15:48
youtube.com

I Ranked Every Way to Lose Visceral Fat — Here's What Actually Works

today
16:21
youtube.com

Your Mitochondria Can Reset - Here’s How

1w ago
0:25
youtube.com

ARA-290: Nerve Pain & Healing Peptide Discovery

1w ago
0:22
youtube.com

Fixing Mitochondria: The TRUTH About SS-31 Peptide

1w ago
18:16
youtube.com

This ONE Blood Test Detects Inflammation Inside You

2w ago
18:10
youtube.com

I Bought Peptides from China

2w ago
1:57
youtube.com

The Social Biological Emergency That Leads to Cortisol Resistance

3w ago
13:27
youtube.com

I Investigated How to Actually Live Longer. We're Missing Something BIG

3w ago
1:01
youtube.com

Mots-C: Pre-workout peptide or just Animal Science?

1mo ago
1:37
youtube.com

The Truth About 5-Amino-1MQ: The Controversial Fat Loss Molecule

1mo ago
1:13
youtube.com

The TRUTH About AOD9604: Fat Loss Hype vs. Reality

1mo ago
See all content